ARMISTICE CAPITAL, LLC

Q3 2024 13F-HR Holdings

Location
New York, NY
Holdings as of
9/30/2024
Date filed
11/14/2024
Form type
13F-HR
Num holdings
258
Total value ($000)
$6,252,651
Net value change ($000)
-1,695,249 (-21.3%)
New positions
79
Sold out positions
72
Turnover %
16.7%
Sector allocation + QoQ delta (equities-only)

Snapshot: Change Analysis

Compared to Q2 2024
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
PTCT 55,510 26.1%
TVTX 45,346 73.6%
INCY 38,229 35.8%
GRFS 34,921 70.2%
DPZ 30,735 240.4%
Inari Medical, Inc. 26,544 54.6%
BUD 23,601 48.4%
S 22,913 220.1%
FIVN 22,031 69.1%
PARAV 21,240 NEW
Top Reduces (Value $000, Stocks/ETFs)
NBIX -113,809 -84.5%
EXAS -59,154 -100.0%
KDP -49,635 -100.0%
SNY -39,355 -54.1%
GSK -36,329 -62.9%
CPB -31,848 -66.0%
MDGL -31,431 -74.8%
KVUE -28,876 -100.0%
KEL -26,045 -100.0%
CRL -24,598 -100.0%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 2,428,844 (38.8% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type